14-day Premium Trial Subscription Sign Up For FreeGet Free

Amicus Therapeutics Stock Forecast NASDAQ:FOLD

$11.25 (0.36%)

Volume: 3M

Closed: Dec 08, 2021

Hollow Logo Score: 0.569

Amicus Therapeutics Stock Forecast

$11.25 (0.36%)

Volume: 3M

Closed: Dec 08, 2021

Score Hollow Logo 0.569
Which way will FOLD go? Request
Stop-loss: $10.79 (-4.12%)
Key Stats
P/E Ratio -13.09
Beta 1.13
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 44 and the stock is currently not being overbought or oversold

Green day on Wednesday for Amicus Therapeutics
(Updated on Dec 08, 2021)

Hold candidate since 2021-12-07 Gain 0.36%

The Amicus Therapeutics stock price gained 0.36% on the last trading day (Wednesday, 8th Dec 2021), rising from $11.21 to $11.25. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 3.70% from a day low at $11.08 to a day high of $11.49. The price has risen in 6 of the last 10 days, but is still down by -0.71% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $39.01 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.07% during the next 3 months and, with a 90% probability hold a price between $10.33 and $13.13 at the end of this 3-month period.

Signals & Forecast

The Amicus Therapeutics stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $10.87 and $11.18. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 7.66%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Amicus Therapeutics finds support from accumulated volume at $11.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.41 between high and low, or 3.70%. For the last week, the stock has had a daily average volatility of 5.21%.

Our recommended stop-loss: $10.79 (-4.12%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Is Amicus Therapeutics stock A Buy?

Amicus Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.569

Predicted Opening Price for Amicus Therapeutics of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$11.27 $11.25 (Undervalued)
Hold/Accumulate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 15, 2021 "Stifel Nicolaus" gave "$12.00 - $16.00" rating for FOLD. The price target was set to $12.07+6.4%.

Volatility and Risk
Daily Average Volatility: 5.21 %
Overall Risk: Very High High Medium Low Very Low
5.21 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $11.34
Price: $11.25
Support: $11.00

FOLD Insider Trading Show all Trades



Last 100 transactions
Buy: 793 727 | Sell: 1 430 652 (Shares)
Date Action Amount Person Type
Dec 01, 2021 Sell 10 515 Campbell Bradley L Stock Options (right to buy)
Dec 01, 2021 Sell 10 515 Campbell Bradley L Common Stock
Dec 01, 2021 Buy 10 515 Campbell Bradley L Common Stock
Nov 15, 2021 Sell 24 935 Crowley John F Stock Options (right to buy)
Nov 15, 2021 Sell 24 935 Crowley John F Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 793 727 | Sell: 1 430 652 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 11.68 3.85 %
11.53 2.46 %
11.43 1.60 %
Current price: 11.25
Support 11.12 -1.18 %
11.02 -2.04 %
10.86 -3.44 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 11.51 2.31 %
11.48 2.04 %
11.34 0.80 %
Current price 11.25
Support 11.00 -2.22%
9.66 -14.13%
9.55 -15.11%

Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical s... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE